These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24723670)

  • 1. GEP-NETS update: functional localisation and scintigraphy in neuroendocrine tumours of the gastrointestinal tract and pancreas (GEP-NETs).
    de Herder WW
    Eur J Endocrinol; 2014 May; 170(5):R173-83. PubMed ID: 24723670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
    Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.
    Chiti A; Fanti S; Savelli G; Romeo A; Bellanova B; Rodari M; van Graafeiland BJ; Monetti N; Bombardieri E
    Eur J Nucl Med; 1998 Oct; 25(10):1396-403. PubMed ID: 9818279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.
    Baumann T; Rottenburger C; Nicolas G; Wild D
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):45-57. PubMed ID: 26971843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostics of neuroendocrine tumours.
    Hodolic M; Fettich J; Banti E; Chondrogiannis S; Al-Nahhas A; Rubello D
    In Vivo; 2010; 24(5):771-4. PubMed ID: 20952747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled somatostatin analogs for radionuclide imaging and therapy in patients with gastroenteropancreatic neuroendocrine tumors.
    Bal CS; Gupta SK; Zaknun JJ
    Trop Gastroenterol; 2010; 31(2):87-95. PubMed ID: 20862981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future prospects of PET-imaging applications in patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).
    Papadakis GZ; Karantanas AH; Marias K; Millo C
    Eur J Radiol; 2021 Oct; 143():109932. PubMed ID: 34482177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
    Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V
    Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary nuclear medicine imaging of neuroendocrine tumours.
    Wong KK; Waterfield RT; Marzola MC; Scarsbrook AF; Chowdhury FU; Gross MD; Rubello D
    Clin Radiol; 2012 Nov; 67(11):1035-50. PubMed ID: 22633086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Georgakopoulos A
    Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
    Ezziddin S; Logvinski T; Yong-Hing C; Ahmadzadehfar H; Fischer HP; Palmedo H; Bucerius J; Reinhardt MJ; Biersack HJ
    J Nucl Med; 2006 Feb; 47(2):223-33. PubMed ID: 16455627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard imaging techniques for neuroendocrine tumors.
    Bushnell DL; Baum RP
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging neuroendocrine tumours with radionuclide techniques.
    Gnanasegaran G; O'Doherty MJ
    Minerva Endocrinol; 2008 Jun; 33(2):105-26. PubMed ID: 18425057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
    Schillaci O; Corleto VD; Annibale B; Scopinaro F; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S186-9. PubMed ID: 10604127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
    Miederer M; Weber MM; Fottner C
    Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent role of (68)Ga-labeled somatostatin analogs in the workup of patients with NETs: AIIMS experience.
    Naswa N; Bal CS
    Recent Results Cancer Res; 2013; 194():321-51. PubMed ID: 22918767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study.
    Naswa N; Sharma P; Kumar A; Nazar AH; Kumar R; Chumber S; Bal C
    AJR Am J Roentgenol; 2011 Nov; 197(5):1221-8. PubMed ID: 22021518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
    Ambrosini V; Tomassetti P; Rubello D; Campana D; Nanni C; Castellucci P; Farsad M; Montini G; Al-Nahhas A; Franchi R; Fanti S
    Nucl Med Commun; 2007 Jun; 28(6):473-7. PubMed ID: 17460538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.